X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES VENUS REMEDIES ALKEM LABORATORIES/
VENUS REMEDIES
 
P/E (TTM) x - -7.8 - View Chart
P/BV x 6.4 0.1 5,214.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   VENUS REMEDIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
VENUS REMEDIES
Mar-17
ALKEM LABORATORIES/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,589143 1,112.7%   
Low Rs1,23265 1,895.4%   
Sales per share (Unadj.) Rs417.5324.2 128.8%  
Earnings per share (Unadj.) Rs56.36.4 878.2%  
Cash flow per share (Unadj.) Rs64.740.6 159.5%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9366.0 80.0%  
Shares outstanding (eoy) m119.5712.34 969.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 1,054.2%   
Avg P/E ratio x25.116.2 154.6%  
P/CF ratio (eoy) x21.82.6 851.3%  
Price / Book Value ratio x4.80.3 1,696.0%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,282 13,154.2%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m9,171251 3,653.9%   
Avg. sales/employee Rs ThNM4,430.1-  
Avg. wages/employee Rs ThNM278.0-  
Avg. net profit/employee Rs ThNM87.6-  
INCOME DATA
Net Sales Rs m49,9154,000 1,247.8%  
Other income Rs m1,64523 7,247.1%   
Total revenues Rs m51,5614,023 1,281.6%   
Gross profit Rs m8,482785 1,081.0%  
Depreciation Rs m1,006422 238.6%   
Interest Rs m671344 195.1%   
Profit before tax Rs m8,45142 20,073.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-37 -4,340.5%   
Profit after tax Rs m6,73179 8,509.7%  
Gross profit margin %17.019.6 86.6%  
Effective tax rate %19.0-87.9 -21.6%   
Net profit margin %13.52.0 682.0%  
BALANCE SHEET DATA
Current assets Rs m27,0622,606 1,038.4%   
Current liabilities Rs m15,3241,980 773.8%   
Net working cap to sales %23.515.6 150.3%  
Current ratio x1.81.3 134.2%  
Inventory Days Days67128 51.8%  
Debtors Days Days4143 95.7%  
Net fixed assets Rs m12,6105,353 235.5%   
Share capital Rs m239123 193.8%   
"Free" reserves Rs m34,4904,393 785.2%   
Net worth Rs m35,0274,516 775.6%   
Long term debt Rs m1,2121,618 74.9%   
Total assets Rs m54,3878,291 656.0%  
Interest coverage x13.61.1 1,211.8%   
Debt to equity ratio x00.4 9.7%  
Sales to assets ratio x0.90.5 190.2%   
Return on assets %13.65.1 266.9%  
Return on equity %19.21.8 1,097.2%  
Return on capital %24.96.3 395.2%  
Exports to sales %12.90-   
Imports to sales %3.118.4 16.8%   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540736 209.2%   
Fx inflow Rs m6,5630-   
Fx outflow Rs m3,012736 409.0%   
Net fx Rs m3,552-736 -482.4%   
CASH FLOW
From Operations Rs m7,259997 727.9%  
From Investments Rs m1,864-461 -404.1%  
From Financial Activity Rs m-9,273-571 1,623.9%  
Net Cashflow Rs m-150-35 427.4%  

Share Holding

Indian Promoters % 66.9 32.9 203.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.2 18,388.9%  
FIIs % 0.0 0.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 66.4 -  
Shareholders   68,381 20,121 339.8%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   FDC LTD.  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at All-Time High; Energy & IT Stocks Top Gainers(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 0.3%.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (4QFY18); Net Profit Down 307.2%

Jun 12, 2018 | Updated on Jun 12, 2018

For the quarter ended March 2018, VENUS REMEDIES has posted a net profit of Rs 94 m (down 307.2% YoY). Sales on the other hand came in at Rs 932 m (up 16.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jul 18, 2018 10:33 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS